Vaccines

Strategies for Ensuring Biomanufacturing Resilience for Biologics

There is consensus among the global health community that long-term collaboration in resilient biomanufacturing capacity and supply chains…

Market Watch & Perspectives on Vaccines Manufacturing in APAC

recently commissioned Economist Intelligence Clearstate, a division of The Economist, to conduct a study on the future of…

What to consider for a modular facility with closed processing

The biopharmaceutical industry trends towards new product classes and smaller batch sizes drives even a greater need for…

Watch on Demand! Advance Scientific Innovation with M Lab™ Collaboration Centers Panel Discussion

Join us for this panel discussion to discover how a large global network of scientific experts, innovative technologies, and non-GMP facilities empower startups to advance scientific innovation through collaborative exploration and learning.

Watch on Demand! 4th Annual Virtual Biotech Startup Symposium

We invite you to the 4th Annual Biotech Start-up Symposium, a free, two-day event to help Biotech Start-ups navigate their path to commercialization. 

Watch on Demand! A Single-use, scale-down solution for intensified development

Traditional scale-down models lack true perfusion capabilities, therefore not optimum for the perfusion media development process. Mobius® Breez microbioreactors with true perfusion capability are highly predictable to larger scale bioreactors, thus significantly enhancing our current workflow.

Webinar: “See How Single-Use Technologies Are Well-suited for the Manufacture of mRNA”

Single-use technologies are well-suited for the manufacture of mRNA. Not only do they offer increased flexibility, they can…

The Future of Biopharma

The Chemical Engineering magazine has published its third article of the biopharmaceutical manufacturing series, written by David Gemmell….

Vaccines Webinar 1st December 2022

Modular Facility Proof-of-Concept for Multi-Modal Bioprocessing: an innovative solution

This webinar describes the collaboration of

Merck KGaA, Darmstadt, Germany
MilliporeSigma
, and G-CON to develop a proof-of-concept facility design that enables multi-modal bioprocessing with greater flexibility and agility which facilitates tech transfer and future expansion.

Biopharmaceutical Manufacturing: An Evolving Industry

Chemical Engineering Magazine has published its second article of the biopharmaceutical manufacturing series, written by Biomanufacturing Engineer, David…

Scroll to Top